Company intelligence / Profile preview

Abela Pharmaceuticals

Lake Forest, California, United Statesaccessdata.fda.gov ↗

Ownership: Private
Development stage: Other

Overview

Abela Pharmaceuticals, Inc. is a private pharmaceutical company founded in 2005 and based in Lake Forest, California. The company has focused on developing small molecule therapeutics for neurological injuries, specifically severe head trauma/craniocerebral trauma. Its lead asset ("AbelaDrug200") reached Phase 1/2 clinical trials to assess safety and preliminary efficacy in patients with closed severe head injury; the trial's current status is unknown as of June 2025. Patent filings suggest expertise in dimethyl sulfoxide (DMSO) and methylsulfonylmethane (MSM) formulations for infectious diseases and other indications.

Therapeutic areas: Neurology
Modalities: Small molecule
Industry: Biotech

Drug pipeline

1 asset

AbelaDrug200

Beyond the preview

Go deeper on Abela Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Abela Pharmaceuticals.

Explore the full profile